Mechanisms of CD40-dependent cDC1 licensing beyond costimulation

Keyphrases

• 4-1BB 16%
• Anti-tumor Response 16%
• Antigen Presentation 16%
• BCL2L1 50%
• Caspase Activation 16%
• CD27 33%
• CD40 100%
• CD40 Signaling 33%
• CD70 33%
• CD8+ T Cells 66%
• CDC1 100%
• CDC1s 66%
• Classical Type 16%
• Costimulation 100%
• Costimulatory Ligand 16%
• Cyclooxygenase-2 16%
• Dendritic Cells 16%
• Induced Gene 16%
• Mitochondrial Transmembrane Potential 16%
• Prostaglandin-endoperoxide Synthase 2 (PTGS2) 16%
• Re-expression 16%
• T Cell Expansion 16%
• T-cell Mediated 16%
• Tumor Immunity 33%
• Tumor Rejection 33%
• Tumor-draining Lymph Nodes 16%
• Tumor-specific 16%

Immunology and Microbiology

• Antigen Presentation 25%
• Caspase 25%
• CD70 50%
• Cell Expansion 25%
• Cytotoxic T-Cell 100%
• Dendritic Cell 25%
• Lymph Node 25%
• Membrane Potential 25%
• Tumor Immunity 50%
• Tumor Rejection 50%